CoChat

Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy

Osella, Alberto R, Misciagna, Giovanni, Guerra, Vito M, Chiloiro, Marisa, Cuppone, Renato, Cavallini, Aldo, Di Leo, Alfredo · 2000 · International Journal of Epidemiology
Cited by 41

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a common cause of chronic liver diseases but the degree to which these diseases contribute to liver-related mortality is not well established. The aim of this study was to estimate the absolute and relative effects of HCV infection on liver-related mortality. METHODS: A population random sample of 2472 subjects aged > or = 30 years was enrolled and followed up from 1985 to 1996. At enrollment, a structured interview and a clinical evaluation were performed. Serum samples were tested using HCV ELISA and RIBA HCV. Outcomes were overall and liver-related mortality and tracing procedures included review of office and hospital records, death certificates, and interviews with general practitioners, attending hospital and next of kin. Statistical analysis was performed using Poisson and binomial prospective data regression. RESULTS: Crude overall and liver-related mortality rates were 7.66 (95% CI : 6.68-8.79) and 0.9 (95% CI : 0.3-2.2) per 10(3) person-years, respectively. For HCV infection effect, incidence rate ratio and difference (per 10(3) person-year), risk ratio and difference were 27.5 (95% CI : 6.5-115.6), 4 (95% CI : 3-7), 33.1 (95% CI : 7.8- 139.3) and 0.06 (95% CI : 0.04-0.08), respectively; all measures were adjusted for age at death, sex and daily alcohol intake. CONCLUSIONS: The results show a strong relative but weak absolute effect of HCV infection on liver-related mortality in the 10-year period considered. Poisson and binomial models are virtually equivalent, but the choice of the summarizing measure of effect may have a different impact on health policy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/29.5.922

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 42

  1. 1 Alter MJ. Epidemiology of hepatitis C. Hepatology1997;26:62S–65S. · DOI · Paper page
  2. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology1991;14:969–74. · DOI · Paper page
  3. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol1992;16: 273–81. · DOI · Paper page
  4. Seef LB, Buskell-Bales Z, Wright EC et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med1992; 327:1906–11. · DOI · Paper page
  5. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis-looking back in the second decade. Ann Intern Med1993;119:110–15. · DOI · Paper page
  6. 6 Kao J-H, Tsai S-L, Chen P-J et al. A clinicopathologic study on chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol1994;21:244–49. · DOI
  7. Sanchez-Tapias JM, Lo Iacono O. Storia naturale dell'infezione cronica da HCV: dall'epatite cronica alla cirrosi. In: Craxì A, Almasio P, Magrin S (eds). Il Virus dell'epatite C (HCV): l'infezione e la malattia. Vol. 2. Milano: Roche, 1995, pp.11–25.
  8. Wejstal R, Hermodsson S, Norkrans G. Long-term follow-up of chronic hepatitis non-A, non-B-with special reference to hepatitis C. Liver1991;11:143–48. · DOI
  9. Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol1992;27:812–16. · DOI
  10. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology1995;21:650–55. · DOI · Paper page
  11. Seef LB and the NHBLI group. Mortality and morbidity of transfusion associated type C hepatitis: an NHLBI multi center study. Hepatology1994;20:204A.
  12. Adagnino V, Stroffolini T, Rapicetta C et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community based survey in Southern Italy. Hepatology1997;26:1006–11 · DOI · Paper page
  13. Kuboki M, Shinzawa H, Shao L et al. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody. Frequency of viremia, biochemical abnormality and histological changes. Liver1999;19:88–96. · DOI
  14. Osella AR, Misciagna G, Leone A, Di Leo A, Fiore G. Epidemiology of hepatitis C virus infection in an area of southern Italy. J Hepatol1997;27:30–35. · DOI
  15. Poynar T, Marcellin P, Lee SS et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet1998;352:1426–32. · DOI · Paper page
  16. Breslow NE, Storer BE. General relative risk functions for case-control studies. Am J Epidemiol1985;122:149–62. · DOI
  17. Breslow NE. Use of the power transform to discriminate between additive and multiplicative models in epidemiologic research. In: Moolgavkar SH, Prentice RL (eds). Modern Statistical Methods in Chronic Disease Epidemiology. New York, NY: John Wiley & Sons, 1986, pp.181–96.
  18. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol1986;123:174–84. · DOI · Paper page
  19. Misciagna G, Leoci C, Elba S et al. The epidemiology of cholelithiasis in southern Italy. Eur J Gastroenterol Hepatol1994;6:937–41. · doi:10.1097/00042737-199410000-00017
  20. Misciagna G, Centonze S, Leoci C et al. Diet, physical activity, and gallstones—a population-based, case-control study in southern Italy. Am J Clin Nutr1999;69:120–26. · DOI · Paper page
  21. Silini EM, Bono F, Cividini A et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology1995;21:285–90. · DOI · Paper page
  22. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol1992;73:673–79. · DOI · Paper page
  23. Russo, F, Cavallini A, Messa C et al. Endogenous sex hormones and cholesterol gallstones: a case-control study in an echographic survey of gallstones. Am J Gastroenterol1993;88:712–17.
  24. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos Study. Hepatology1994;20:1442–49. · DOI · Paper page
  25. Pagliaro L, Rinaldi F, Craxì A et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. Dig Dis Sci1983;28:39–43. · DOI · Paper page
  26. Colombo M. Hepatocellular carcinoma in cirrhotics. Semin Liver Dis1993;13:374–83. · doi:10.1055/s-2007-1007366
  27. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology1993;105:274–78. · DOI · Paper page
  28. Frome EL. The analysis of rates using Poisson regression models. Biometrics1983;39:665–74. · DOI · Paper page
  29. Frome EL, Checkoway H. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol1985;121:309–23. · DOI · Paper page
  30. Macaluso M. Exact stratification of person-years. Epidemiology1992; 3:441–48. · doi:10.1097/00001648-199209000-00010
  31. Capocaccia R, Farchi G. Mortality from liver cirrhosis in Italy: proportion associated with consumption of alcohol. J Clin Epidemiol1988;41:347–57. · doi:10.1016/0895-4356(88)90142-4
  32. GLIM system, Release 3.77. Oxford, England: The Numerical Algorithms Group, 1985.
  33. Schatzkin A, Slud E. Competing risks bias arising from an omitted risk factor. Am J Epidemiol1989;129:850–56. · doi:10.1093/oxfordjournals.aje.a115199
  34. Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated with Hepatitis C virus infection. N Engl J Med1993;328:465–70. · DOI · Paper page
  35. De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter study. Hepatology1994;20:1225–30. · DOI · Paper page
  36. Rothman KJ, Greenland S (eds). Modern Epidemiology. 2nd Edn. Philadelpia: Lippincott-Raven 1998.
  37. Pagliaro L, Peri V, Linea C, Cammà C, Giunta M, Magrin S. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol1999;31: 28–44.
  38. Layde PM, Broste SK, Desbiens N et al. Generalizability of clinical studies conducted at tertiary care medical centers: a population-based analysis. J Clin Epidemiol1996;49:835–41. · DOI
  39. Osella AR, Sonzogni L, Cavallini A et al. Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. J Clin Microbiol1999;37:2371–72. · DOI
  40. Greenland S, Robins J. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol1988;128: 1185–97. · DOI · Paper page
  41. Mangia A, Schiavone G, Lezzi G et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol1998;93: 2363–67. · DOI
  42. Maggi G, Bottelli R, Gola D et al. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol1996;28:436–40.

Cited by

See all 41

Metadata

Authors
Osella, A. R., Misciagna, G., Guerra, V. M., Chiloiro, M., Cuppone, R., Cavallini, A., & Di Leo, A.
Venue
International Journal of Epidemiology
Published
2000-10
Volume
29
Issue
5
Pages
922-927
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2150391556
Cited by
41
References
3
FWCI
0.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. https://app.cochat.ai/papers/10.1093/ije/29.5.922
The paper
Osella, A. R., Misciagna, G., Guerra, V. M., Chiloiro, M., Cuppone, R., Cavallini, A., & Di Leo, A. (2000). Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. International Journal of Epidemiology. https://doi.org/10.1093/ije/29.5.922

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.